Evidence map›Paper›PMID 31420559›Full record

ArticleNature communications2019

On demand delivery and analysis of single molecules on a programmable nanopore-optofluidic device.

M Rahman, M A Stott, M Harrington, Y Li, M J N Sampad, L Lancaster, T D Yuzvinsky, H F Noller, A R Hawkins, H Schmidt

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Specialized ribosomes: integrating new insights and current challenges.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2025
    Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

M RahmanSchool of Engineering, University of California Santa Cruz, 1156 High Street, Santa Cruz, CA, 95064, USA.
M A StottECEn Department, Brigham Young University, 459 Clyde Building, Provo, UT, 84602, USA.
M HarringtonSchool of Engineering, University of California Santa Cruz, 1156 High Street, Santa Cruz, CA, 95064, USA.
Y LiSchool of Engineering, University of California Santa Cruz, 1156 High Street, Santa Cruz, CA, 95064, USA.
M J N SampadSchool of Engineering, University of California Santa Cruz, 1156 High Street, Santa Cruz, CA, 95064, USA.
L LancasterDepartment of Molecular, Cell and Developmental Biology and Center for Molecular Biology of RNA, University of California at Santa Cruz, 1156 High Street, Santa Cruz, CA, 95064, USA.
T D YuzvinskySchool of Engineering, University of California Santa Cruz, 1156 High Street, Santa Cruz, CA, 95064, USA.ORCID http://orcid.org/0000-0001-5708-2877
H F NollerDepartment of Molecular, Cell and Developmental Biology and Center for Molecular Biology of RNA, University of California at Santa Cruz, 1156 High Street, Santa Cruz, CA, 95064, USA.
A R HawkinsECEn Department, Brigham Young University, 459 Clyde Building, Provo, UT, 84602, USA.
H SchmidtSchool of Engineering, University of California Santa Cruz, 1156 High Street, Santa Cruz, CA, 95064, USA. hschmidt@soe.ucsc.edu.
University of California, Santa Cruz · USBrigham Young University · US

Funding

Ribosome Structure and FunctionR35GM118156 · NIGMS · UNIVERSITY OF CALIFORNIA SANTA CRUZ · PI NOLLER, HARRY F · 2016 to 2025
$7.8M
Hybrid integrated molecular analysis (HIMAS) for point-of-care diagnosticsR33AI100229 · NIAID · UNIVERSITY OF CALIFORNIA SANTA CRUZ · PI SCHMIDT, HOLGER · 2014 to 2016
$1.7M
Hybrid integrated molecular analysis (HIMAS) for point-of-care diagnosticsR21AI100229 · NIAID · UNIVERSITY OF CALIFORNIA SANTA CRUZ · PI SCHMIDT, HOLGER · 2012 to 2013
$448k
NIAID NIH HHS R21 AI100229NIAID NIH HHS R33 AI100229
6 · The paper itself

Abstract

Nanopore-based single nanoparticle detection has recently emerged as a vibrant research field with numerous high-impact applications. Here, we introduce a programmable optofluidic chip for nanopore-based particle analysis: feedback-controlled selective delivery of a desired number of biomolecules and integration of optical detection techniques on nanopore-selected particles. We demonstrate the feedback-controlled introduction of individual biomolecules, including 70S ribosomes, DNAs and proteins into a fluidic channel where the voltage across the nanopore is turned off after a user-defined number of single molecular insertions. Delivery rates of hundreds/min with programmable off-times of the pore are demonstrated using individual 70S ribosomes. We then use real-time analysis of the translocation signal for selective voltage gating of specific particles from a mixture, enabling selection of DNAs from a DNA-ribosome mixture. Furthermore, we report optical detection of nanopore-selected DNA molecules. These capabilities point the way towards a powerful research tool for high-throughput single-molecule analysis on a chip.

Indexed as

Lab-On-A-Chip DevicesNanoporesOptical DevicesDNAEscherichia coliRibosomesSingle Molecule ImagingDNA

Identifiers

PMID31420559
PMCPMC6697697
OpenAlexW2967114524

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.